BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ACell, Inc. MatriStem® Products Demonstrated to be Effective on Hard to Heal Wounds


4/24/2013 9:54:04 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

COLUMBIA, Md., April 24, 2013 /PRNewswire/ -- ACell MatriStem® medical devices were featured in a peer-reviewed article, "Porcine Urinary Bladder matrix: a Retrospective Study and Establishment of Protocol," published in the October, 2012 issue of the Journal of Wound Care (www.journalofwoundcare.com). Analysis showed a decrease in mean closure time after application of MatriStem in wounds that had received previous applications of other advanced wound care products. All wounds utilizing MatriStem achieved complete closure including those with exposed bone, tendon, and joint closure in the thirty-four patient study. In the study MatriStem was shown to be a novel advanced wound care modality in the treatment of complex lower extremity diabetic, venous insufficient, ischemic and decubitus ulcers.

(Logo: http://photos.prnewswire.com/prnh/20130424/PH00029LOGO)

Patients were treated with MatriStem medical devices, the only commercially available form of urinary bladder matrix (UBM), at the Eastern Colorado Health Care System, Veterans Affairs (VA) Medical Center in Denver, CO. The study was independent in nature. No external sources of funding for this study were received by the authors or the VA. The authors had no conflicts of interest to declare.

"We are very satisfied with the results of this independent study on non-healing wounds. MatriStem has shown to be effective where other products fail," Rodney Bosley, ACell President & COO said. "Results like these have established ACell as a leader in Regenerative Medicine."

MatriStem medical devices are porcine-derived extracellular matrix (ECM) that maintain and support a healing environment through constructive remodeling, and are available in particle and sheet forms by prescription only. Refer to IFU supplied with each device for indications, contraindications, and precautions.

ACell, Inc. offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix products to repair and remodel damaged tissues in a broad range of applications. ACell's patented ECM medical devices address important clinical needs, while providing safe, effective, economical and therapeutic outcomes to the wound care and surgical communities. These devices, trademarked as MatriStem, are appropriate for acute wounds, chronic wounds and various surgical procedures. All MatriStem devices are made in the USA. For more information, call (800) 826-2926 or visit www.acell.com.

SOURCE ACell, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES